新冠肺炎奥密克戎变异株中成药应用专家共识  

Expert Consensus on Application of Chinese Patent Medicine of COVID-19 Omicron Mutant

作　　者：方邦江[1] 齐文升[2] 任毅 周爽[4] 陈晓蓉 曹敏[1] 邓跃毅[1] 郭建文[6] 刘力[7] 刘婉嫣[8] 廖成荣 李旭成[10] 石李[1] 孙鼎[1] 宋娟 叶勇[11] 杨志旭[12] 尹琴 伍宏泽 郑偕扣[15] 郑月娟[4] 张文 张硕 张翔宇[16] FANG Bangjiang;QI Wensheng;REN Yi;ZHOU Shuang;CHEN Xiaorong;CAO Min;DENG Yueyi;GUO Jianwen;LIU Li;LIU Wanyan;LIAO Chengrong;LI Xucheng;SHI Li;SUN Ding;SONG Juan;YE Yong;YANG Zhixu;YIN Qin;WU Hongze;ZHENG Xiekou;ZHENG Yuejuan;ZHANG Wen;ZHANG Shuo;ZHANG Xiangyu(Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Guang anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100000,China;Chongqing Hospital of Traditional Chinese Medicine,Chongqing 400010,China;Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Shanghai Public Health Center,Shanghai 201500,China;Guangdong Hospital of Traditional Chinese Medicine,Guangzhou 510120,China;Epidemic Research Institute,Shaanxi University of Chinese Medicine,Shaanxi Xianyang 712046,China;Jilin Integrated Hospital of Traditional Chinese and Western Medicine,Jilin Jilin 132000,China;Dianjiang County Hospital of Traditional Chinese Medicine,Chongqing 408399,China;Wuhan Hospital of Traditional Chinese Medicine,Wuhan 430000,China;Yunnan Provincial Hospital of Traditional Chinese Medicine,Kunming 650500,China;Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China;Hubei Integrated Hospital of Traditional Chinese and Western Medicine,Wuhan 430010,China;Jiujiang Hospital of Traditional Chinese Medicine,Jiangxi Jiujiang 332000,China;The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300150,China;The Tenth People s Hospital Affiliated to Tongji University,Shanghai 200072,China)

机构地区：[1]上海中医药大学附属龙华医院,上海200032 [2]中国中医科学院广安门医院,北京100000 [3]重庆市中医医院,重庆400010 [4]上海中医药大学,上海201203 [5]上海市公共卫生中心,上海201500 [6]广东省中医院,广东广州510120 [7]陕西中医药大学疫病研究院,陕西咸阳712046 [8]吉林市中西医结合医院,吉林吉林132000 [9]重庆市垫江县中医院,重庆408399 [10]武汉市中医医院,湖北武汉430000 [11]云南省中医医院,云南昆明650500 [12]中国中医科学院西苑医院,北京100091 [13]湖北省中西医结合医院,湖北武汉430010 [14]九江市中医医院,江西九江332000 [15]天津中医药大学第二附属医院,天津300150 [16]同济大学附属第十人民医院,上海200072

出　　处：《陕西中医药大学学报》2022年第6期1-7,共7页Journal of Shaanxi University of Chinese Medicine

基　　金：国家中医药管理局2022年第五批新型冠状病毒感染肺炎中医药应急专项课题(2022ZYLCYJ05-4);上海中医药大学2022年度应对奥密克戎感染新型冠状病毒肺炎应急攻关项目(2022YJ-03,2022YJ-06)。

摘　　要：新冠肺炎自2020年爆发以来,中医药取得举世瞩目的救治效果,在全球疫情防控中发挥着重要作用,获得了WHO的高度肯定。2021年11月新冠肺炎奥密克戎(Omicron)变异株首次出现并迅速传播,我国吉林、上海先后出现爆发并蔓延全国。为了更加有效应对奥密克戎变异株感染,世界中医药学会联合会急症专业委员会、中华医学会急诊分会中西医结合急救学组、中国医师协会急诊医师分会中西医结合急救医学学组、上海中医药学会急诊分会、上海中医药大学急危重研究所等学术机构组织奥密克戎新冠肺炎变异株一线救治专家,根据上海、吉林等奥密克戎感染地区患者中医临床症候,并结合国家《新型冠状病毒诊疗方案(试行第九版)》,就中成药应用相关问题展开调研与讨论,形成本共识,以期对当下新冠肺炎奥密克戎变异株感染乃至以后疫情防控起到临床指导作用。Since the outbreak of COVID-19 in 2020,Chinese medicine has achieved remarkable treatment results,played an important role in the global epidemic prevention and control,and was highly recognized by WHO.In November 2021,the COVID-19 Omicron mutant appeared for the first time and spread rapidly.Jilin and Shanghai in China successively broke out and spread throughout the country.In order to more effectively respond to the infection of Omikron’s variant strain,the World Federation of Chinese Medical Societies Emergency Committee,the First Aid Group of Integrated Traditional Chinese and Western Medicine of the Emergency Branch of the Chinese Medical Association,the First Aid Group of Integrated Traditional Chinese and Western Medicine of the Emergency Branch of the Emergency Physician Branch of the Chinese Medical Association,the Emergency Branch of the Shanghai Chinese Medical Association,the Institute of Emergency and Critical Care of the Shanghai University of Traditional Chinese Medicine and other academic institutions have organized first-line treatment experts for Omikron’s COVID-19 variant strain.The clinical symptoms of patients in Jilin and other areas infected with Omikron were investigated and discussed on issues related to the application of Chinese patent medicine in combination with the National Diagnosis and Treatment Plan forCOVID-19(Trial Version 9),and a consensus was formed,with a view to playing a clinical guiding role in the prevention and control of the current infection of Omikron variant of COVID-19 and the future epidemic situation.

关 键 词：新型冠状病毒 奥密克戎 中医 中成药 专家共识 

分 类 号：R286[医药卫生—中药学]